TSP Capital Management Group’s AbbVie ABBV Stock Holding History

TSP Capital Management Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Hold	0	–	–	–	47
2019 Q2	–	Hold	0	–	–	–	51
2019 Q1	–	Sell	-6,048	Closed	-$495K	–	49
2018 Q4	$558K	Buy	+6,048	New	+$532K	0.31%	47
2018 Q3	–	Sell	-6,048	Closed	-$574K	–	49
2018 Q2	$560K	Hold	6,048	–	–	0.29%	49
2018 Q1	$572K	Sell	6,048 -1,300	-18%	-$143K	0.27%	50
2017 Q4	$711K	Hold	7,348	–	–	0.32%	47
2017 Q3	$653K	Buy	+7,348	New	+$559K	0.31%	49
2017 Q2	–	Hold	0	–	–	–	51
2017 Q1	–	Hold	0	–	–	–	52
2016 Q4	–	Hold	0	–	–	–	53
2016 Q3	–	Sell	-8,398	Closed	-$544K	–	50
2016 Q2	$520K	Hold	8,398	–	–	0.27%	49
2016 Q1	$480K	Sell	8,398 -3,550	-30%	-$198K	0.26%	49
2015 Q4	$708K	Buy	11,948 +500	+4%	+$28.8K	0.38%	52
2015 Q3	$623K	Hold	11,448	–	–	0.35%	54
2015 Q2	$769K	Buy	+11,448	New	+$747K	0.36%	52
2015 Q1	–	Hold	0	–	–	–	55
2014 Q4	–	Hold	0	–	–	–	52
2014 Q3	–	Sell	-11,548	Closed	-$641K	–	54
2014 Q2	$652K	Buy	+11,548	New	+$606K	0.28%	53
2014 Q1	–	Hold	0	–	–	–	55
2013 Q4	–	Hold	0	–	–	–	54
2013 Q3	–	Hold	0	–	–	–	55
2013 Q2	–	Hold	0	–	–	–	56

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

TSP Capital Management Group's ABBV Position: Q3 2019 in Review

TSP Capital Management Group held its AbbVie (ABBV) position steady in Q3 2019 at 0 shares worth $458K. The position accounts for 0.23% of the portfolio, ranked #47.

TSP Capital Management Group first reported a position in ABBV in Q2 2014 and has held it in 11 quarters since. The position peaked at $769K in Q2 2015. 2,003 funds tracked by Wall St. Rank hold ABBV as of Q3 2019.

TSP Capital Management Group held 0 shares of AbbVie worth $458K as of Q3 2019.
TSP Capital Management Group left its AbbVie share count unchanged in Q3 2019.
AbbVie made up 0.23% of TSP Capital Management Group's portfolio in Q3 2019, its #47 holding.
TSP Capital Management Group first reported a position in AbbVie in Q2 2014 and has held it in 11 quarters since.
TSP Capital Management Group's AbbVie position peaked at $769K in Q2 2015.
2,003 funds tracked by Wall St. Rank held AbbVie as of Q3 2019.

Based on TSP Capital Management Group's 13F filing for Q3 2019, filed 14 Nov 2019.